Apax to buy Israeli aesthetic device firm Syneron for $397 mln
April 03, 2017 at 07:34 AM EDT
TEL AVIV, April 3 (Reuters) - British private equity firm Apax Partners has agreed to buy Israel's Syneron Medical Ltd, a non-surgical aesthetic device company, for $11.00 per share in cash, or a total of $397 million, the companies said on Monday.